Literature DB >> 30638238

Solution-phase total synthesis of teixobactin.

Bowen Gao1, Sigui Chen, Yun Nan Hou, Yong Juan Zhao, Tao Ye, Zhengshuang Xu.   

Abstract

The first solution-phase total synthesis of the cyclic depsipeptide teixobactin is described. Stereoselective construction of l-allo-enduracididine was established, and the protective groups for the peptide coupling reactions and conditions for the assembly of the fragments were also optimised. The longest linear sequence for the total synthesis was 20 steps from the known l-cis-4-hydroxyproline derivative and gave a 5.6% overall yield. This solution-phase total synthesis could serve as a complement to the current solid-phase synthesis of teixobactin.

Entities:  

Year:  2019        PMID: 30638238     DOI: 10.1039/c8ob02803f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  Characterization of a Citrulline 4-Hydroxylase from Nonribosomal Peptide GE81112 Biosynthesis and Engineering of Its Substrate Specificity for the Chemoenzymatic Synthesis of Enduracididine.

Authors:  Christian R Zwick; Max B Sosa; Hans Renata
Journal:  Angew Chem Int Ed Engl       Date:  2019-11-11       Impact factor: 15.336

2.  Harnessing the biocatalytic potential of iron- and α-ketoglutarate-dependent dioxygenases in natural product total synthesis.

Authors:  Christian R Zwick; Hans Renata
Journal:  Nat Prod Rep       Date:  2020-02-14       Impact factor: 13.423

3.  Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism.

Authors:  Qianhui Wu; Biswajit Mishra; Guangshun Wang
Journal:  Pept Sci (Hoboken)       Date:  2022-04-25

4.  De Novo Resistance to Arg10-Teixobactin Occurs Slowly and Is Costly.

Authors:  Daniel G Lloyd; Benjamin J Schofield; Matthew R Goddard; Edward J Taylor
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

Review 5.  Old and modern antibiotic structures with potential for today's infections.

Authors:  David J Newman
Journal:  ADMET DMPK       Date:  2022-03-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.